Patent details

EP1809662 Title: DEAMIDATED INTERFERON-BETA

Basic Information

Publication number:
EP1809662
PCT Application Number:
PCT/US/2005/040758
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP058182353
PCT Publication Number:
WO/2006/053134
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DEAMIDATED INTERFERON-BETA
French Title of Invention:
INTERFERON BETA DESAMINE
German Title of Invention:
DEAMIDIERTES INTERFERON-BETA
SPC Number:

Dates

Filing date:
10/11/2005
Grant date:
26/11/2008
EP Publication Date:
26/11/2008
PCT Publication Date:
18/05/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/07/2007
EP B1 Publication Date:
26/11/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/11/2009
Expiration date:
10/11/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/11/2005
 
 

Name:
Novartis Vaccines and Diagnostics Inc.
Address:
4560 Horton Street, Emeryville, CA 94608-2916, United States (US)

Inventor

1

Name:
JOHNSON-JACKSON Deborah
Address:
United States (US)

2

Name:
FURUYA Kenji
Address:
United States (US)

3

Name:
RUSCIO Diana, Tierra
Address:
United States (US)

Priority

Priority Number:
626837 P
Priority Date:
10/11/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 14/565;
Filing date Document type Number of pages